(Reuters) — Attorneys for 2 patients infected with a drug-resistant bacterial "superbug" during medical procedures in a Los Angeles hospital, 1 of whom died, have sued the maker of the devices used in their care.
Olympus
FDA seeks to speed updates to “superbug” device labels
FDA warns on ERCP endoscope, CRE “superbug” link

The FDA is warning that ERCP endoscopes may allow for the transmission of certain drug-resistant “superbugs,” even if the devices are properly cleaned.
The advisory was issued in the wake of news that contaminated endoscopes are suspected of causing a deadly outbreak of the superbug CRE, or carbapenem-resistant enterobacteriaceae (CRE), among patients at the UCLA Ronald Reagan Medical Center in Los Angeles.
FDA knew devices spread fatal ‘superbug’ but does not order fix
(Reuters) – U.S. health regulators have known since at least 2009 that the medical devices at the center of the "superbug" outbreak at UCLA can transmit lethal infections but have not recommended any new safety requirements, a lapse that threatens patient safety, experts in hospital-acquired infections said.
Olympus in talks to end U.S. kickbacks probe
Olympus accuses ex-sales manager, ArthroCare | Medtech legal news for the week of June 23, 2014
Olympus concedes biotech defeat, shutters OP-1 plant

Olympus goes after ex-sales manager, ArthroCare
